Umb Bank, N.A. Biomarin Pharmaceutical Inc Transaction History
Umb Bank, N.A.
- $5.92 Billion
- Q1 2025
A detailed history of Umb Bank, N.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 2,247 shares of BMRN stock, worth $134,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,247
Previous 1,019
120.51%
Holding current value
$134,078
Previous $66,000
139.39%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BMRN
# of Institutions
629Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.36 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.16 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.09 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$880 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$775 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...